In the latest episode of Executing the Vision, Brad Hunter of Emerge Labs interviews Wayne Woodard, CEO of Argonaut Manufacturing Services, who shares his journey from
Biopharma gains a seamless transition from drug discovery through drug product manufacturing San Diego, CA, June 20, 2024 – Abzena, the leading end-to-end integrated contract
How resilient is your manufacturing strategy in the face of potential disruptions to the pharmaceutical supply chain? As we navigate the complex landscape of aseptic
Argonaut Manufacturing Services Expands Aseptic Pharmaceutical Fill / Finish Capabilities with $45 Million Equity Investment from NewVale Capital and Telegraph Hill Partners Investment strengthens Argonaut’s
Supporting Orphan Drug Aseptic Fill Finish Rare diseases, also known as orphan diseases, are a group of diverse and often life-threatening conditions that collectively affect
Why Your Biotech Contract Manufacturer is Expanding in Combination Product and Drug-Fill/Finish in 2024 Letter to Our Colleagues, from Founder/CEO Wayne Woodard, Argonaut Manufacturing Services
KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions Alliance
As we wrap up 2023 and look ahead to 2024, the biotech industry reflects on a challenging year behind us marked by the aftermath of
… but things may be looking up. Marketplace Podcast, Interview With CEO Wayne Woodard Public media podcast, Marketplace, delves into the intricate responses of manufacturing
In this n-Lorem podcast episode, Bottling Hope, host Stan Crook introduces guest Wayne Woodard, CEO of Argonaut. Wayne details his background in industrial technology, emphasizing